b2venture

B2venture is a venture capital firm established in 2000 and based in Saint Gallen, Switzerland. The firm specializes in early-stage investments, focusing on high-growth companies within various sectors, including artificial intelligence, machine learning, automation, advanced materials, biotech, climate technology, fintech, healthcare, logistics, and more. B2venture invests over EUR 100 million annually, with individual investment sizes ranging from EUR 0.25 million to EUR 3.5 million. Through its targeted approach, the firm aims to support innovative companies across Europe, fostering advancements in technology and business solutions.

Anna Bosch

Principal

Jan-Hendrik Buerk

Partner

Johanna Junkermann

Investment Manager

Christian Schütz

Partner

Sabrina Stöckl

Principal

Michael Wieser

Partner

Past deals in Procurement

VESTIGAS

Seed Round in 2025
VESTIGAS specializes in streamlining Purchase-to-Pay processes in the construction industry. It develops software that facilitates structured data exchange, offering features such as automatic invoice verification, real-time data tracking, and comprehensive auditing tools. This enables clients to efficiently automate their delivery processing.

Vamstar

Series A in 2022
Vamstar operates a B2B healthcare supply chain platform that addresses inefficiencies in the sourcing and procurement processes for medical devices and pharmaceuticals. By utilizing advanced data automation technologies such as machine learning, Vamstar aggregates demand from millions of sources, creating a comprehensive marketplace that connects buyers, including hospitals and health systems, with a vast network of suppliers. The platform provides real-time analytics and valuable tools for search and bid development, allowing users to quickly identify suitable opportunities and finalize transactions. With access to a significant volume of global demand and millions of contracts, Vamstar simplifies the procurement process, helping healthcare organizations reduce costs and improve access to essential products and services. The company is dedicated to building a digital marketplace that fosters innovation in healthcare and is supported by leading investors in the field.

Vamstar

Seed Round in 2021
Vamstar operates a B2B healthcare supply chain platform that addresses inefficiencies in the sourcing and procurement processes for medical devices and pharmaceuticals. By utilizing advanced data automation technologies such as machine learning, Vamstar aggregates demand from millions of sources, creating a comprehensive marketplace that connects buyers, including hospitals and health systems, with a vast network of suppliers. The platform provides real-time analytics and valuable tools for search and bid development, allowing users to quickly identify suitable opportunities and finalize transactions. With access to a significant volume of global demand and millions of contracts, Vamstar simplifies the procurement process, helping healthcare organizations reduce costs and improve access to essential products and services. The company is dedicated to building a digital marketplace that fosters innovation in healthcare and is supported by leading investors in the field.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.